Citric Acid Cycle Is Also Known As

Why the Citric Acid Cycle Goes by So Many Names (And Why It Matters)

Here's something that trips up biology students and curious minds alike: walk into three different classrooms or翻 three different textbooks, and you'll hear the same biochemical pathway referred to by three completely different names. Citric acid cycle. Krebs cycle. Worth adding: tCA cycle. Same pathway, different labels — and that inconsistency can make even a straightforward topic feel unnecessarily confusing.

The citric acid cycle is one of the most fundamental processes in biochemistry. That said, it's the engine room of cellular respiration, the series of chemical reactions that powers nearly every living cell on Earth. Understanding what it does — and what it's called — matters more than most people realize.

So let's clear this up. By the end of this article, you'll know every name this cycle goes by, where those names come from, and why understanding the citric acid cycle (regardless of what you call it) is essential for anyone studying life sciences, medicine, or human health.

What Is the Citric Acid Cycle?

The citric acid cycle is a series of chemical reactions that occurs in the mitochondria of cells. It's the third stage of cellular respiration, following glycolysis and the electron transport chain. But here's the thing — it doesn't just "happen." It has a specific job: to extract high-energy electrons from acetyl-CoA and carry them to the next stage of energy production.

In plain terms, the cycle takes the energy from the food you eat and converts it into a form your cells can actually use. Worth adding: that's the short version. The longer version involves eight enzyme-catalyzed steps, and that's where things get interesting.

Now, about those names. The cycle is called the citric acid cycle because citrate (a derivative of citric acid) is the first molecule formed when the cycle begins. It's also called the tricarboxylic acid cycle or TCA cycle — TCA refers to the tricarboxylic acids involved in the process, and you'll often see it written this way in scientific literature.

Then there's the name that honors the scientist who most thoroughly unraveled it: the Krebs cycle, after Hans Krebs, who won the Nobel Prize in Physiology or Medicine in 1953 for this discovery.

Why Three Names for One Pathway?

History explains this. Now, " The TCA nomenclature came later, adopted by biochemists who wanted a more chemically precise label. Hans Krebs published his detailed description of the cycle in 1937, and for years it was known mainly as the citric acid cycle in American textbooks. British and European scientists more commonly used "Krebs cycle.So rather than choosing one official name, the field simply kept all three in rotation.

Why the Citric Acid Cycle Matters

Think of the citric acid cycle as the middleman of cellular energy production. Without it, the energy from glucose can't fully be extracted. Glycolysis alone produces a small amount of ATP, but the real payoff comes from what happens next — and the citric acid cycle is where most of that happens.

During one turn of the cycle, one acetyl-CoA molecule enters and produces three NADH molecules, one FADH₂, one GTP (which is functionally equivalent to ATP), and releases two CO₂ molecules. Those NADH and FADH₂ carriers then shuttle their electrons to the electron transport chain, where the bulk of ATP synthesis occurs.

What does this mean in practice? When your cells need to build new molecules, they often pull starting materials from the citric acid cycle. It means that every breath you take, every heartbeat, every thought — all of it runs on energy that passed through the citric acid cycle at some point. The cycle also provides precursors for biosynthesis. It's not just an energy factory; it's a biochemical crossroads.

Why Scientists Still Debate Its Name

You might think naming conventions would be settled after 80 years. They're not. In academic papers, you might see "citric acid cycle" preferred in clinical contexts, "TCA cycle" in biochemistry research, and "Krebs cycle" in educational settings. Each field has its habits.

Hans Krebs himself actually disliked the eponym, preferring the chemically descriptive name. He felt that attaching a person's name to a fundamental biological process overstated individual contribution in a field built on collective discovery. Whether you find that humble or principled, it's worth knowing the scientist behind the name had mixed feelings about it.

How the Citric Acid Cycle Works

Here's how the cycle actually operates. Now, it begins when acetyl-CoA — derived from carbohydrates, fats, or proteins — enters the cycle by combining with oxaloacetate to form citrate. From there, the cycle proceeds through eight distinct steps, each catalyzed by a specific enzyme.

1. Citrate synthase combines acetyl-CoA with oxaloacetate to form citrate.
2. Aconitase converts citrate into isocitrate.
3. Isocitrate dehydrogenase oxidizes isocitrate, releasing CO₂ and producing NADH — this is the first CO₂ release.
4. α-Ketoglutarate dehydrogenase converts α-ketoglutarate to succinyl-CoA, producing another NADH and releasing the second CO₂.
5. Succinyl-CoA synthetase converts succinyl-CoA to succinate, generating one GTP (or ATP).
6. Succinate dehydrogenase converts succinate to fumarate, producing FADH₂.
7. Fumarase converts fumarate to malate.
8. Malate dehydrogenase converts malate back to oxaloacetate, producing another NADH.

And then the cycle is ready to start again. Consider this: one acetyl-CoA generates the equivalent of approximately 10 ATP molecules when you account for the subsequent electron transport chain activity. That's efficient — at least by biological standards.

The Role of Mitochondria

Everything happens in the mitochondrial matrix, the innermost compartment of the mitochondria. This compartmentalization isn't trivial. Consider this: the enzymes that drive the cycle are arranged in a supramolecular complex, meaning they're physically clustered together to make the reactions more efficient. Substrates pass from one enzyme to the next without fully dissociating, kind of like an assembly line with no gaps.

This spatial organization is one reason mitochondrial function is so tightly linked to overall metabolic health. When mitochondria are damaged — by aging, disease, or oxidative stress — the citric acid cycle slows down, and cellular energy production suffers.

Common Mistakes and What People Get Wrong

Thinking the cycle produces ATP directly. It doesn't. The cycle generates one GTP per turn, which is quickly converted to ATP, but the bulk of ATP production comes from the electron transport chain using the NADH and FADH₂ produced by the cycle. Students often miss this distinction and overestimate how much ATP the cycle itself generates.

Forgetting that the cycle runs twice per glucose molecule. Glycolysis produces two pyruvate molecules, each of which becomes one acetyl-CoA. So for every glucose, the citric acid cycle turns twice. That matters when you're calculating total ATP yield from glucose oxidation.

Confusing the citric acid cycle with the electron transport chain. These are separate stages of cellular respiration, though they're tightly linked. The ETC relies on the NADH and FADH₂ produced by the cycle, but the cycle itself doesn't involve electron transport or chemiosmosis. Students sometimes blur these steps together.

**Assuming

Assuming that the cycle can generate all the ATP needed by the cell without the electron‑transport chain is a trap that many students fall into. In reality, the citric‑acid cycle’s net direct output is a single GTP (equivalent to ATP) per turn; the bulk of usable energy comes from the NADH and FADH₂ that feed the ETC. Without the downstream oxidative‑phosphorylation machinery, the cycle would quickly stall because NAD⁺ and FAD would become depleted.

Other Frequent Misconceptions

Continuous influx of carbon is not a trivial side‑note; it is a fundamental requirement for the citric‑acid cycle to sustain itself over the long term. When an acetyl‑CoA molecule is fully oxidized, the two carbon atoms that entered as the acetyl group are released as CO₂, and the four‑carbon backbone of oxaloacetate is left intact. If nothing else were to happen, the cycle would indeed continue indefinitely because oxaloacetate is regenerated. On the flip side, the situation in a living cell is far more dynamic. Biosynthetic pathways constantly withdraw intermediates—α‑ketoglutarate for glutamate synthesis, succinyl‑CoA for porphyrin formation, oxaloacetate for gluconeogenesis, and citrate for fatty‑acid synthesis—creating a net loss of cycle intermediates. This process, termed cataplerosis, depletes the pool that would otherwise be available for the next turn. To maintain homeostasis, the cell must replace the missing carbons through anaplerotic (Greek for “filling up”) reactions.

Anaplerosis: Feeding the Cycle

The balance between anaplerosis and cataplerosis is not static; it shifts with the cell’s metabolic state. In the fed state, insulin promotes glycolysis and pyruvate carboxylase activity, thereby increasing oxaloacetate levels to support fatty‑acid synthesis. During fasting, glucagon stimulates proteolysis, releasing amino acids that are deaminated by GDH, feeding α‑ketoglutarate into the cycle

For more on this topic, read our article on tin indium silver alloy differential scanning calorimeter or check out mantle ridge plan to revitalize air products.

During fasting, the surge in glucagon triggers a cascade that catabolises skeletal‑muscle protein and mobilises glucogenic amino acids. Alanine, glutamine, and branched‑chain amino acids are trans‑aminated in the cytosol or mitochondria to their corresponding α‑keto acids, which then enter the TCA cycle at several points. Think about it: glutamate, for example, is deaminated by mitochondrial glutamate dehydrogenase (GDH), generating α‑ketoglutarate and releasing ammonia for the urea cycle. This influx of α‑ketoglutarate constitutes a major anaplerotic input that sustains the cycle when the supply of acetyl‑CoA from β‑oxidation is insufficient to meet the energetic demand of the liver. Concurrently, pyruvate derived from glycolysis or from alanine transamination can be carboxylated to oxaloacetate by pyruvate carboxylase (PC), an enzyme that is allosterically activated by acetyl‑CoA and potently induced by insulin signaling. The resulting rise in oxaloacetate restores the pool that is drawn upon for gluconeogenesis, thereby coupling anaplerosis to the body’s need to maintain blood glucose during prolonged starvation.

Molecular regulation of anaplerotic enzymes

• Pyruvate carboxylase – The biotin‑dependent carboxylase is inactive in the absence of its obligate activator, acetyl‑CoA. As a result,

when fatty‑acid β‑oxidation yields high levels of mitochondrial acetyl‑CoA, PC is allosterically switched on, linking substrate availability directly to anaplerosis. Glucagon also up‑regulates PC transcription via cAMP‑responsive elements, while insulin antagonises this effect, creating a hormonal “switch” that favours anaplerosis during fasting and limits it in the fed state. Worth adding, PC is acetylated on lysine residues by the acetyltransferase p300; this reversible modification increases its affinity for acetyl‑CoA and protects the enzyme from ubiquitination‑mediated degradation, thereby providing a post‑translational layer of control.

• Glutamate dehydrogenase (GDH) – Mammalian GDH is a homo‑hexameric enzyme that can use either NAD⁺ or NADP⁺ as a co‑factor, but its activity is heavily regulated by a suite of allosteric effectors. ADP and GDP act as potent activators, signalling low energy charge and the need for oxidative phosphorylation. Conversely, GTP, NADH, palmitoyl‑CoA, and leucine exert inhibitory influences. In the liver, fasting‑induced rises in glucagon and glucocorticoids increase GDH expression, while insulin‑stimulated Akt phosphorylates GDH at Ser⁴⁸⁴, dampening its activity. The net result is a rapid, reversible adjustment of α‑ketoglutarate production that matches the fluctuating demand for anaplerosis.

• Malic enzyme (ME1/ME2) – The cytosolic isoform ME1 converts malate to pyruvate while generating NADPH, a reducing equivalent that is essential for reductive biosynthesis such as fatty‑acid synthesis. ME2, located in the mitochondria, operates in the opposite direction, converting pyruvate to malate and replenishing oxaloacetate. Both isoforms are induced by the transcription factor SREBP‑1c under insulin‑rich conditions, linking NADPH production to lipogenesis. Conversely, during nutrient deprivation, AMPK phosphorylates ME1 at Thr⁷⁴, inhibiting its activity and conserving carbon for gluconeogenesis.

• Phosphoenolpyruvate carboxykinase (PCK1/2) – PCK1 (cytosolic) and PCK2 (mitochondrial) catalyse the GTP‑dependent decarboxylation of oxaloacetate to phosphoenolpyruvate, the first committed step of gluconeogenesis. PCK1 expression is tightly controlled by the glucagon‑cAMP‑PKA axis and by glucocorticoids, both of which are elevated during fasting. The peroxisome proliferator‑activated receptor γ coactivator‑1α (PGC‑1α) cooperates with HNF4α to drive PCK1 transcription, while insulin‑stimulated Akt phosphorylates FoxO1, causing its nuclear export and repression of the PCK1 promoter. Such multilayered regulation ensures that cataplerotic flux is synchronized with hepatic glucose output.

Physiological outcomes of anaplerosis in liver

The net effect of anaplerosis is the maintenance of the TCA‑cycle intermediate pool at a size sufficient to support both energy production and biosynthetic pathways. , during prolonged fasting or a high‑fat diet), the cycle is “pulled” forward, depleting OAA and α‑KG unless anaplerotic substrates compensate. g.When the liver is flooded with acetyl‑CoA from enhanced β‑oxidation (e.Conversely, in the postprandial state, excess carbohydrate provides pyruvate that can be converted to OAA, a substrate that can either continue through the TCA cycle for oxidation or be diverted toward citrate for fatty‑acid synthesis.

If anaplerosis is insufficient, several metabolic derangements may arise:

• Hypoglycaemia – Inadequate OAA generation limits gluconeogenic flux, impairing the liver’s capacity to release glucose during fasting.
• Hyperammonemia – Without sufficient GDH activity, nitrogen from amino‑acid catabolism cannot be efficiently incorporated into α‑KG, leading to ammonia accumulation.
• Mitochondrial dysfunction – Depletion of TCA intermediates compromises oxidative phosphorylation, reducing ATP yields and promoting oxidative stress.

Conversely, excessive anaplerosis can fuel pathological processes:

• Hepatic steatosis – Persistent activation of PC and malic enzyme supplies ample OAA and NADPH, driving de‑novo lipogenesis and triglyceride accumulation.
• Cancer metabolism – Many tumours up‑regulate anaplerotic enzymes (PC, GDH) to sustain rapid proliferation, a phenomenon now being targeted by specific small‑molecule inhibitors.

Integration with systemic metabolism

Anaplerosis in the liver is not an isolated event; it is tightly interwoven with extra‑hepatic tissues through circulating substrates and hormonal cues. Still, during prolonged fasting, adipose‑derived glycerol and muscle‑derived lactate provide additional carbon skeletons that can be converted to pyruvate and subsequently to OAA via PC. Adiponectin and fibroblast growth factor 21 (FGF21), both elevated in fasting, enhance hepatic expression of GDH and PC, reinforcing anaplerotic capacity.

In the fed state, dietary carbohydrates saturate the glycolytic pathway, producing abundant pyruvate. Day to day, insulin‑mediated activation of PC ensures that a fraction of this pyruvate is diverted to OAA, which can be condensed with acetyl‑CoA to form citrate. Cytosolic citrate is then cleaved by ATP‑citrate lyase to generate acetyl‑CoA for fatty‑acid synthesis, linking anaplerosis to lipogenesis.

Exercise introduces another layer of complexity. Contracting skeletal muscle releases lactate and alanine into the bloodstream; the liver takes up these gluconeogenic precursors, converting them via the Cori and glucose‑alanine cycles. The resultant pyruvate is partially carboxylated to OAA (anaplerosis) and partially dec

partially decarboxylated to pyruvate, creating a balanced flux that supports both gluconeogenesis and TCA cycle replenishment. This coordinated exchange between muscle and liver exemplifies how anaplerosis serves as a metabolic interface, enabling organ cross-talk under varying physiological demands.

Hormonal regulation of anaplerotic enzymes

The hepatic anaplerotic program is under stringent hormonal control, ensuring that carbon entry into the TCA cycle aligns with the organism's nutritional status. Glucagon, released during fasting, activates a signaling cascade involving PKA that phosphorylates and inhibits pyruvate dehydrogenase (PDH), thereby shunting pyruvate away from acetyl‑CoA production and toward OAA synthesis via PC. Simultaneously, glucagon upregulates PC expression through CREB‑dependent transcription, amplifying the liver's anaplerotic capacity.

Insulin exerts opposite effects, promoting glycolysis and acetyl‑CoA generation while suppressing PC transcription. Even so, insulin also stimulates acetyl‑CoA carboxylase (ACC), which produces malonyl‑CoA to inhibit CPT1, thereby preventing fatty‑acid oxidation and preserving acetyl‑CoA for lipogenesis. This reciprocal regulation ensures that anaplerosis and cataplerosis remain temporally coordinated with feeding and fasting cycles.

Glucocorticoids and thyroid hormone further modulate anaplerotic enzyme expression. Cortisol enhances proteolysis in peripheral tissues, supplying amino‑acid substrates that can be deaminated to α‑KG, while T3 upregulates GDH and PC genes, increasing the liver's baseline anaplerotic potential. The concerted action of these hormones allows precise tuning of TCA cycle intermediates in response to chronic metabolic stress.

Clinical implications and therapeutic targeting

Dysregulation of hepatic anaplerosis is increasingly recognized as a contributor to metabolic disease. In non‑alcoholic fatty liver disease (NAFLD), sustained activation of PC and malic enzyme promotes lipogenesis, while impaired cataplerosis reduces export of citrate-derived acetyl‑CoA, leading to intracellular triglyceride accumulation. Strategies aimed at restoring the balance—such as PC inhibitors or cataplerosis-promoting agents—are under investigation as potential treatments.

Inborn errors of metabolism affecting anaplerotic enzymes, including pyruvate carboxylase deficiency and GDH mutations, illustrate the critical nature of these pathways. Patients present with hypoglycemia, lactic acidosis, and neurological impairment, underscoring how disrupted carbon flow through the TCA cycle reverberates across systemic metabolism.

Emerging therapeutic approaches include allosteric modulators of GDH (e.And , metformin, which indirectly suppresses activity) and dietary interventions that provide anaplerotic substrates. Day to day, g. Here's a good example: supplementation with odd-chain fatty acids, which yield propionyl‑CoA during β‑oxidation, can enhance gluconeogenesis by replenishing TCA intermediates through the propionyl‑CoA pathway.

Conclusion

Anaplerosis represents a fundamental metabolic node that bridges energy production, biosynthesis, and systemic homeostasis. Adequate anaplerotic flux is essential for gluconeogenesis during fasting, ammonia detoxification, and maintenance of mitochondrial ATP generation, while excessive anaplerosis can drive pathological states including hepatic steatosis and tumor growth. Integration with hormonal signals, inter-organ substrate exchange, and dietary cues ensures that anaplerotic activity is finely tuned across the fed-fasted cycle and in response to physiological stressors. Still, through enzymes such as pyruvate carboxylase, glutamate dehydrogenase, and malic enzyme, the liver dynamically regulates TCA cycle intermediate pools to meet shifting physiological demands. Understanding these regulatory networks offers not only insight into normal metabolism but also promising avenues for therapeutic intervention in metabolic disorders, cancer, and inherited metabolic diseases.